EGF stimulation in U87 and LN229 GBM cells increased TRIM24 expression and its association with H3K23ac, and the treatment with the EGFR tyrosine kinase inhibitor erlotinib attenuated both (Fig. 2b). This evidence concerns the gene EGF and glioblastoma.